solifenacin succinate

FDA Drug Profile — solifenacin succinate, Solifenacin Succinate, Solifenacin succinate, VESIcare, VESIcare LS

Drug Details

Generic Name
solifenacin succinate
Brand Names
solifenacin succinate, Solifenacin Succinate, Solifenacin succinate, VESIcare, VESIcare LS
Application Number
ANDA215761
Sponsor
Camber Pharmaceuticals, Inc.
NDC Codes
19
Dosage Forms
TABLET, FILM COATED, POWDER, TABLET, COATED, TABLET, FILM COATED, EXTENDED RELEASE, SUSPENSION
Routes
ORAL
Active Ingredients
SOLIFENACIN SUCCINATE

Indications and Usage

1 INDICATIONS AND USAGE Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. ( 1 )